Technology Criteria for the Manufacturing of Rebamipide Film-coated Tablets

QR Code

Technology Criteria for the Manufacturing of Rebamipide Film-coated Tablets

Show other versions (1)

Introduction. The current growth of the pharmaceutical market and stiff competition require from drug manufacturers make a more detailed and thorough fine-tuning of existing production lines. Direct compression technology is a modern and cost-effective technology for solid dosage form drug manufactu...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. V. Trusov, B. V. Brovchenko, Z. M. Kozlova, I. I. Krasnyuk
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2023-12-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	rebamipide direct compression dry granulation film-coated tablets
Online Access:	https://www.pharmjournal.ru/jour/article/view/1663
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Technology criteria for the manufacturing of Rebamipide film-coated tablets
by: G. V. Trusov, et al.
Published: (2024-09-01)

Assessment of the plasticity of dry granulated particles (mini-tablets) and its relationship to their tabletability
by: Maryam Tofiq, et al.
Published: (2025-12-01)

Evaluation of Vibratory Ball Mill Mixing as an Alternative to Wet Granulation in the Manufacturing of Sodium Naproxen Tablets with Dolomite-Based Formulations
by: Mateusz Przywara, et al.
Published: (2025-06-01)

Development of Amlodipine Mini-tablets as a Polypill-component for the Personalized Therapy of Arterial Hypertension
by: K. M. Tserkovnaya, et al.
Published: (2023-12-01)

Comparison of the Therapeutic Effects of Rebamipide and Diquafosol on Apoptotic Damage of the Ocular Surface in Dry Eyes
by: Enying Jiang, et al.
Published: (2025-06-01)

Development of Celecoxib Granules for Manufacturing of Prolonged Release Celecoxib Capsules and Tablets
by: A. Alkhodri, et al.
Published: (2022-02-01)

Problems of Applying Film Coatings During Scale-up Technology
by: A. V. Strelkova, et al.
Published: (2022-11-01)

Development of the technology of tablets on the basis of ademetionine 1,4-butanedisulfonate
by: K. S. Burdak, et al.
Published: (2017-04-01)

Tablet manufacture /
by: Johnson, J. C. (Jeanne Colbert), 1920-
Published: (1974)

PHARMACEUTICAL DEVELOPMENT: REVIEW OF EQUIPMENT FOR LABORATORY DEVELOPMENT AND PILOT BATCHES PRODUCTION OF SOLID DOSAGE FORMS
by: N. B. Diomina
Published: (2019-01-01)

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer’s Disease
by: Israa J. Hakeem, et al.
Published: (2025-05-01)

STUDIES OF THE DEVELOPMENT OF ORO-DISPERSIBLE TABLETS WITH AZITHROMYCIN
by: T. A. Pankrusheva, et al.
Published: (2019-01-01)

Optimizing the treatment for gastroesophageal reflux disease in young people: the role and place of rebamipide
by: I.M. Skrypnyk, et al.
Published: (2025-03-01)

Preventive Effect of Rebamipide Gargle on Chemoradiotherpy-Induced Oral Mucositis in Patients with Oral Cancer: a Pilot Study
by: Takashi Yasuda, et al.
Published: (2011-11-01)

A Technology for Forming Tablet Cores of Complex Geometric Shapes for Further Coating, with a Multivitamin Product as a Case Study
by: V. V. Kosenko, et al.
Published: (2025-05-01)

Prediction of the composition of prolonged release tablets based on 4,4'-(propandiamido) sodium dibenzoate using the SeDeM method
by: Ju. M. Kotsur, et al.
Published: (2021-12-01)

The use of compaction in the manufacture of tablets
by: O. V. Tryhubchak, et al.
Published: (2016-08-01)

Stage control of tablets manufacturing
by: L. I. Kucherenko, et al.
Published: (2014-08-01)

ON THE STRENGTH AND FRIABILITY OF SERIES PRODUCTS MANUFACTURED BY DIRECT COMPRESSION OF NON-METALLIC GRANULES
by: Oleksii Gubenia, et al.
Published: (2025-09-01)

REBAMIPIDE: EFFECTIVE DRUG PREVENTION OF NSAID ENTEROPATHY IS POSSIBLE
by: E. V. Moroz, et al.
Published: (2016-12-01)

Excipients choice justification for the creation of Adamantane-1ammonium 2-((5-(adamantane-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate tablets by the method of wet granulation (part 2)
by: V. M. Odyntsova, et al.
Published: (2017-08-01)

USE OF DISSOLUTION TEST FOR EVALUATION OF PHARMACEUTICAL EQUIVALENCE OF ATORVASTATIN GENERICS
by: O. V. Druzhininskaya, et al.
Published: (2019-01-01)

Development of Dihydroquercetin-based Oral tablets and Evalution of the General Toxic Effect
by: S. A. Abdulrazzak, et al.
Published: (2022-05-01)

DEVELOPMENT OF PERORAL HYPOLIPIDEMIC FORMULATION BASED ON SULFATED ARABINOGALACTAN IN THE FORM OF POTASSIUM SALT
by: Ya. A. Kostyro, et al.
Published: (2021-12-01)

Development of Enteric-coated Tablets of Sodium 4,4'-(propnadiamido)dibenzoate
by: Ju. M. Kotsur, et al.
Published: (2022-05-01)

Comparison of granulated lactose properties produced by various wet granulation methods without the use of binders
by: A. E. Baldaev, et al.
Published: (2025-06-01)

Study on optimal concentration of uniconazole in rape coating agent and field effect of film coating on rape seed germination and subsequent growth of seedlings
by: QIU Jun, et al.
Published: (2004-03-01)

Study of the technological properties of excipients in the development of the composition of orally dispersible tablets
by: I. D. Kasymov, et al.
Published: (2021-12-01)

DEVELOPMENT OF NITROFURAN DERIVATIVE: COMPOSITION AND TECHNOLOGY OF EFFERVESCENT TABLETS WITH SOLID DISPERSIONS
by: A. O. Elagina, et al.
Published: (2022-03-01)

Study of the Effect of Matrix-forming Polymers on the Release Rate of Sodium 4,4'-(propanediamido)dibenzoate from Tablets
by: Yu. M. Kotsur, et al.
Published: (2023-12-01)

Efficacy of Nirmatrelvir tablet/Ritonavir tablet in patients infected with COVID-19 aged 90 years and older
by: WEI Xueman, et al.
Published: (2025-05-01)

Wet granulation method in the technology of 6,8-dimethyl-2-piperidinomethyl-2,3-dihydrothiazolo[2,3-F]xanthine tablets, which increases the detoxifying function of the liver
by: A. I. Petrakov, et al.
Published: (2025-06-01)

Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01)

Insights into the preparation, properties, application in food of polysaccharide-based edible films and coatings: An updated overview
by: Hongkun Xue, et al.
Published: (2025-01-01)

The Role of the Geometric Configuration of Diethylaminoethanol Derivative in the Pharmaceutical Development of a Dosage Form Based on It
by: Yu. M. Kotsur, et al.
Published: (2023-12-01)

New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)
by: A. I. Martynov, et al.
Published: (2020-05-01)

Development of the Tablet Dosage Form Composition for the Inductor of Hepatocytes Monooxygenase System Based on 6,8-dimethyl-2-piperidinomethyl-2,3-dihydrothiazolo[2,3-F]xanthine
by: A. I. Petrakov, et al.
Published: (2023-12-01)

Development of the composition of the tablets "Cardiosten" using the method of mathematical planning of the experiment
by: O. S. Kukhtenko, et al.
Published: (2019-08-01)

VITAMIN C AND CRANBERRY EXTRACT EFFERVESCENT TABLET FORMULATION, CHARACTERIZATION, AND EVALUATION
by: Haider Ali Gillani, et al.
Published: (2023-03-01)

EVALUATION OF THE AUTOMATION INFLUENCE ON THE DISSOLUTION VARIABILITY RESULTS FOR BETASERC TABLETS
by: N. S. Dubovik, et al.
Published: (2019-01-01)